news roundup
Parexel and Pamplona Capital Management have entered into an agreement under which Pamploma will acquire Parexel for $5 billion. The deal is expected to close early in Q4 this year.
| advertisment
A New Paradigm: Cutting-edge Processes and Analytics in Site and Patient Selection
Live Webinar: Thursday, July 20 at 11:00am EDT
 Register now |
Continuum Clinical will use its expertise in observational research with Skipta's social network of specialized online medical communities to form the Center for Observational Research that will connect physicians with opportunities in real-world research.
| advertisment
Minimal Residual Disease Detection: Key Considerations for Clinical Development in Oncology
Live Webcast: Thursday, June 29 at 11:00am EDT
 Register now |
In anticipation of an expected uptick in the number of companies adopting eConsent, CRF Health announced TrialConsent Version 2, which offers a fully embedded design tool.
| advertisment
Shortening Biosimilar Development: A Case Study Integrating Early Clinical (Phase I) with late phase (Phase III) Biosimilars Development
Live Webinar: Thursday, June 27 at 11:00am EDT
 Register now |
Read up on the most recent people moves and business recognitions and milestones.
| advertisment
Coming to terms with Patient Centricity
On Demand
 Learn more |
|
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
| advertisment
Capturing Continuous Glucose Monitoring Advantages
Live Webinar: Wednesday, June 28 at 11:00am EDT
 Register now |
Blog Posts
IRT bridges the gap between clinical and supply, and how interactive response technologies (IRT) can be leveraged to enable innovative trial designs.
| advertisment
Selecting and Auditing a Technology Vendor for Biopharmaceutical Development
On Demand
 Learn more |
|
|
Articles
In this article, published on the month of Applied Clinical Trials 25th Anniversary, we examine the changes in the industry, with an eye to the near future.
| advertisment
Emerging Biopharma and Rare Disease: Finding a Needle in a Haystack
Data-driven Patient Recruitment Solutions
On Demand
 Learn more |
Ken Getz reports on Tufts CSDD data that shows early signs of a maturing and scaling landscape in North America, along with a slowing of globalization.
| advertisment
Talking the Patients' Language – the importance of effective, patient-centered engagement
On Demand
 Learn more |
|
|
|
RBM
In this on-demand webcast from QuintilesIMS, the speakers discuss how data truly does transform a company's monitoring efforts, and answer audience questions on RBM and centralized monitoring.
| advertisment
Achieve Better Outcomes with New RBM Tech Enhancements
On Demand
 Learn more |
It is strongly recommended that a risk-based approach to software validation be assessed for any medical software/app, even those not being used in clinical trials, as there are moral and ethical issues if any software used for medical decision-making does not act as intended.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
